5-(N,N-dimethyl)-Amiloride Hydrochloride: Selective NHE1 Inhibitor for Intracellular pH and Cardiovascular Research

Executive Summary: 5-(N,N-dimethyl)-Amiloride (hydrochloride) (DMA) is a small-molecule inhibitor with submicromolar affinity for the Na+/H+ exchanger NHE1 (Ki = 0.02 µM), NHE2 (Ki = 0.25 µM), and NHE3 (Ki = 14 µM), enabling precise modulation of intracellular pH and sodium homeostasis in mammalian cells (APExBIO). DMA demonstrates protective effects against cardiac ischemia-reperfusion injury by normalizing tissue sodium and pH, as well as inhibiting ouabain-sensitive ATPase activity and alanine uptake in hepatocytes under controlled conditions (Chen et al., 2021). Its selectivity profile minimizes off-target effects on NHE4, NHE5, and NHE7. The compound is highly soluble in DMSO and DMF (up to 30 mg/ml at room temperature), but stock solutions require -20°C storage and should be used promptly. 5-(N,N-dimethyl)-Amiloride hydrochloride is for research use only—its utility in diagnostic or clinical settings is unsupported.

Biological Rationale

Intracellular pH (pHi) regulation is essential for metabolic activity, cell proliferation, and survival in mammalian cells. The Na+/H+ exchanger (NHE) family, particularly NHE1, NHE2, and NHE3 isoforms, mediates the electroneutral exchange of intracellular H+ for extracellular Na+, maintaining pHi and cell volume (Chen et al., 2021). Dysregulated NHE activity is linked to cardiac ischemia, hypertrophy, and endothelial barrier dysfunction. In sepsis and cardiovascular disease, endothelial cell injury and increased permeability are driven by disrupted NHE signaling and cytoskeletal dynamics, with moesin (MSN) serving as a biomarker of vascular damage (Chen et al., 2021). Selective inhibition of NHE1 by 5-(N,N-dimethyl)-Amiloride disrupts this pathological signaling, positioning DMA as an indispensable tool in cardiovascular and inflammation research.

Mechanism of Action of 5-(N,N-dimethyl)-Amiloride (hydrochloride)

5-(N,N-dimethyl)-Amiloride hydrochloride is a structural analog of amiloride. It binds to the intracellular domain of NHE1, NHE2, and NHE3 and competitively inhibits Na+/H+ exchange. This action blocks the extrusion of protons (H+) and uptake of sodium ions (Na+), resulting in acidification of the cytosol and altered sodium balance (APExBIO). DMA exhibits high selectivity: NHE1 is inhibited at nanomolar concentrations (Ki = 0.02 µM), NHE2 at submicromolar (Ki = 0.25 µM), and NHE3 at micromolar (Ki = 14 µM) levels. NHE4, NHE5, and NHE7 are not significantly affected at standard research concentrations. DMA also inhibits ouabain-sensitive ATP hydrolysis and Na+/K+ ATPase activity in rat liver plasma membranes. In hepatocytes, it reduces alanine uptake, confirming its broader effects on ion transport.

Evidence & Benchmarks

• DMA (0.02 µM) potently inhibits NHE1-mediated Na+/H+ exchange in mammalian cells, leading to measurable cytosolic acidification under physiological buffer conditions (APExBIO).
• DMA administration in rat cardiac tissue during ischemia-reperfusion normalizes tissue sodium, reduces contractile dysfunction, and decreases tissue injury markers (Chen et al., 2021).
• In vitro, DMA inhibits ouabain-sensitive ATPase activity by over 60% in rat liver plasma membranes at 10 µM, indicating robust effects on sodium transport (APExBIO).
• DMA demonstrates minimal inhibition of NHE4, NHE5, and NHE7 at concentrations up to 100 µM, confirming isoform selectivity (APExBIO).
• DMA reduces alanine uptake in isolated hepatocytes by 40% at 10 µM, linking Na+/H+ exchanger activity to amino acid transport (APExBIO).

Applications, Limits & Misconceptions

DMA is widely used in research on intracellular pH regulation, cardiovascular disease models, and endothelial dysfunction. It is particularly valuable in dissecting NHE1-driven pathways in cell signaling and organ injury. In comparison to other reviews, this article provides updated benchmarks for DMA's selectivity and translational impact, clarifying its use in cardiac and endothelial injury models. For advanced protocols and troubleshooting, see this article; here, we extend the discussion to practical integration and storage parameters. For a comprehensive look at Na+/H+ exchanger signaling, this source provides broader context, while the present article focuses on DMA's unique selectivity and workflow fit.

Common Pitfalls or Misconceptions

• DMA is not suitable for clinical or diagnostic use; it is for research applications only.
• Long-term storage of DMA solutions (>1 week) leads to degradation; always prepare fresh aliquots and store at -20°C.
• DMA does not significantly inhibit NHE isoforms 4, 5, or 7 at concentrations relevant for cell-based assays.
• Solubility is limited in aqueous buffers; dissolution should be in DMSO or DMF up to 30 mg/ml.
• DMA's effects on Na+/H+ exchanger activity may alter other sodium-dependent transporters, requiring careful experimental controls.

Workflow Integration & Parameters

DMA (C3505) from APExBIO is supplied as a crystalline solid and can be dissolved in DMSO or DMF at concentrations up to 30 mg/ml. Stock solutions must be stored at -20°C and are not recommended for long-term storage. Working concentrations typically range from 0.01 µM to 20 µM, depending on the NHE isoform and cell type targeted. For NHE1 inhibition, 0.02–0.2 µM is effective. Use freshly diluted solutions for each experiment. DMA is compatible with live-cell imaging, intracellular pH assays, and ion transport studies. For troubleshooting, refer to advanced protocols in this resource.

Conclusion & Outlook

5-(N,N-dimethyl)-Amiloride (hydrochloride) is a cornerstone tool for research on Na+/H+ exchanger signaling, endothelial injury, and cardiovascular disease. Its high selectivity, robust inhibition profile, and proven impact in organ injury models make it indispensable for both fundamental and translational studies. Ongoing research will clarify its role in other sodium-dependent transport pathways and in emerging models of inflammation. For product access and technical details, visit the APExBIO product page.